Elicera Therapeutics AB (OSTO:ELIC) Institutional Ownership : 0.01% (As of Sep. 21, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Elicera Therapeutics AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Elicera Therapeutics AB's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Elicera Therapeutics AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Elicera Therapeutics AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Elicera Therapeutics AB Institutional Ownership Historical Data

The historical data trend for Elicera Therapeutics AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elicera Therapeutics AB Institutional Ownership Chart

Elicera Therapeutics AB Historical Data

The historical data trend for Elicera Therapeutics AB can be seen below:

	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31	2024-06-30	2024-07-31	2024-08-31
Institutional Ownership	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.02	0.01

Elicera Therapeutics AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Elicera Therapeutics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elicera Therapeutics AB (OSTO:ELIC) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

Massans gata 10, World Trade Center Goteborg, 7th Floor, Goteborg, SWE, SE-412 51

Website

https://www.elicera.com

Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments. The company's product portfolio consists of four drug candidates, two in the field of oncolytic viruses (ELC-100 and ELC-201) and two in the field of CAR T-cell treatments (ELC-301 and ELC-401), in addition to a universal CAR T-cell technology platform, iTANK (ELC-001), compatible with any CAR T-cell therapy for a multi-targeted attack on solid tumors.

Elicera Therapeutics AB Headlines

No Headlines